Author: vicky
Certara, 과학적 혁신의 가속화에 대한 예측을 제공하는 인공 지능 회사 Vyasa 인수
Certara improves software capabilities by expanding into deep learning and data fabric PRINCETON, N.J.— 1월 4, 2023 — Certara, Inc. 글로벌 바이오시뮬레이션 선두기업(Nasdaq: CERT), today announced it has acquired Vyasa Analytics, LLC. Vyasa provides scalable deep-learning software which allows life sciences organizations to perform predictions and answer complex questions across structured and unstructured bio-medical information. The acquisition will elevate Certara’s software by bringing state-of-the-art artificial intelligence (AI) capabilities to its end-to-end platform. “We are pleased to … Continued
Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
Arsenal will acquire approximately 30M shares at $15 per share from funds controlled by EQT Private Equity and agrees to two-year lock-up on sale of shares PRINCETON, N.J.— 11월 7, 2022 — Certara, Inc. 글로벌 바이오시뮬레이션 선두기업(Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and building transformational healthcare … Continued
Project Optimus: How to engage with the FDA to advance your program
Join us for this SPECIAL SESSION taking place during DIA Global 2022. This is a cocktail reception with presentation and Q&A hosted by Julie Bullock, PharmD & ex FDA and Demetrius Carter at the Hyatt Regency McCormick Place. Given the launch of Project Optimus, how do you best navigate the evolving regulatory landscape and determine … Continued
PharmaSUG 2022: May 22-25 in Austin, TX
Prediction of drug-drug interactions with oxycodone and pupil constriction using a physiologically based pharmacokinetic-pharmacodynamic model
TOPRA Regulatory Careers Live – 2022
Quantitative Systems Pharmacology Conference (QSPC2022)
Accelerating Pediatric Drug Development: Regulatory and Industry Perspectives
Certara, University of Cape Town and Pharmacometrics Africa Partner on Fellowship Program in Africa for Applied Pharmacometrics Training
PRINCETON, N.J.— 3월 29, 2022 — Certara, Inc, a global leader in biosimulation, and Pharmacometrics Africa NPC, today announced a partnership with the University of Cape Town (UCT) to support its fellowship program for doctoral-level scientists from Africa. The Fellowship program builds scientific and leadership capability in the region by enhancing the skills of scientists and … Continued
